Finance

Lists
4506:TYO
Sumitomo Pharma Co Ltd
JP¥ १,५९१.५०
+०.५४%
(+८.५०) 1D
अक्टोबर ९, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4506...
Open
JP¥ १,५६८
High
JP¥ १,६०५
Low
JP¥ १,५५६
Mkt. cap
७.१५ खरब
Avg. vol.
३४.६२ लाख
Volume
३३.९८ लाख
P/E ratio
५.६९
52-wk high
JP¥ ३,२८८
52-wk low
JP¥ १,१८८
EPS
JP¥ २८०
Shares outstanding
३९.७३ करोड
No. of employees
३ हजार
Open
JP¥ १,५६८
High
JP¥ १,६०५
Low
JP¥ १,५५६
Mkt. cap
७.१५ खरब
Avg. vol.
३४.६२ लाख
Volume
३३.९८ लाख
P/E ratio
५.६९
52-wk high
JP¥ ३,२८८
52-wk low
JP¥ १,१८८
EPS
JP¥ २८०
Shares outstanding
३९.७३ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Curzio Research
Curzio Research
·
२१ मिनेट पहिले
A silent bear market hiding under the S&P 500’s record high
Simply Wall Street
Simply Wall Street
·
६ मिनेट पहिले
Lucid Group (LCID) Sets Up France Launch With More Than 16 Locations
Yahoo Finance
Yahoo Finance
·
४ घण्टा पहिले
A handful of tech stocks are masking an ugly S&P 500 problem
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees३.१२ हजार
Founded१८९७ मे १४
HeadquartersOsaka, Osaka, जापान
Sector-
Last report
२०२६ जुलाई ३१
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
१.२९ खरब / १.१४ खरब
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१९ खरब
१.२१ खरब
१.०६ खरब
१.२९ खरब
Cost of goods sold
४५.५९ अरब
५५.४४ अरब
५१.२६ अरब
६१.४१ अरब
Cost of revenue
४५.५९ अरब
५५.४४ अरब
५१.२६ अरब
६१.४१ अरब
Research and development expenses
९.३५ अरब
१०.३५ अरब
१६.१२ अरब
११.४३ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४०.९० अरब
४२.९४ अरब
४३.५२ अरब
३९.२४ अरब
Operating expense
-१.०४ अरब
५२.१९ अरब
१.१० खरब
५०.३३ अरब
Total operating expenses
४४.५५ अरब
१.०८ खरब
१.६१ खरब
१.१२ खरब
Operating income
७४.५७ अरब
१३.०० अरब
-५५.८१ अरब
१७.७५ अरब
Other non operating income
-
-
-१.६४ अरब
-
EBT including unusual items
८०.८७ अरब
८.७४ अरब
-१.२० अरब
१८.३० अरब
EBT excluding unusual items
८०.८७ अरब
८.७४ अरब
-५१.०० अरब
१८.३० अरब
Income tax expense
-६.७८ अरब
-८.०० करोड
-३८.३० करोड
१.३० अरब
Effective tax rate
-८.३९%
-०.९२%
३२.०५%
७.०९%
Other operating expenses
-५१.३० अरब
-१.१० अरब
५०.४५ अरब
-३३.७० करोड
Net income
८७.६५ अरब
८.८२ अरब
-८१.२० करोड
१७.०० अरब
Net profit margin
७३.५८%
७.३१%
-०.७७%
१३.१३%
Earnings per share
-
-
-
-
Interest and investment income
५.११ अरब
२५.८० करोड
४.६४ अरब
२.२० अरब
Interest expense
-
-५.१४ अरब
-
-२.०९ अरब
Net interest expenses
५.११ अरब
-४.८८ अरब
४.६४ अरब
१०.७० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७९.८५ अरब
१८.३२ अरब
-५२.४८ अरब
२२.६५ अरब
Gain or loss from assets sale
१.९६ अरब
-
-
-
AI content may include mistakes. Learn more
Google एपहरू